EW Q3'26 Earnings: revenue estimate is 1.68B USD

What happened

Edwards Lifesciences will report Q3'26 results on November 04 after the market closes, at 3:15 PM ET. The revenue estimate is 1.68 billion USD and the earnings per share estimate is 0.74 USD.

Confirmed

Global impact / market context

The revenue estimate is a forecast of sales, and the earnings per share estimate is a forecast of profit per share. Whether actual results beat or miss these forecasts can shift the stock price because investors judge future profit on them.

Analyst inference

The article shows Edwards beat revenue estimates in the prior four quarters and beat earnings per share estimates in three of them. That history may shape how investors judge the new results, though past beats do not guarantee future ones.

Analyst inference

What to watch

1. Watch whether reported revenue for Q3'26 comes in above or below the 1.68 billion USD estimate, which is the figure provided by FactSet. Confirmed
2. Compare reported earnings per share with the 0.74 USD estimate, since a miss or beat can change how investors value future profit per share. Proposed
3. Watch whether sales growth continues the recent trend, because slower revenue could pressure profit and affect how the stock is priced after the release. Analyst inference

Evidence

• Original source link unavailable